A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications

Abstract There have been 774,075,242 cases of COVID-19 and 7,012,986 deaths worldwide as of January 2024. In the early stages of the pandemic, there was an urgent need to reduce the severity of the disease and prevent the need for hospitalization to avoid stress on healthcare systems worldwide. The...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mani Iyer Prasanth, Dhammika Leshan Wannigama, Angela Michelle Reiersen, Premrutai Thitilertdecha, Anchalee Prasansuklab, Tewin Tencomnao, Sirikalaya Brimson, James Michael Brimson
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2024-06-01
Col·lecció:	Scientific Reports
Matèries:	(E)‐5‐methoxy‐1‐[4‐(trifluoromethyl)phenyl]pentan‐1‐one O‐2‐aminoethyl oxime) SARS-CoV-2 Pandemic Sigma-1 receptor (σ1R) Drug repurposing
Accés en línia:	https://doi.org/10.1038/s41598-024-64260-9
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!